Delivery Order SPE2DB22D1106-SPE2DB25FETN2

Award Date 6/14/25
Potential Completion Date 6/16/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $9,849.54 for the supply of AMOX-CLAV 875-125 MG TABLET UD 100S, a generic pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,523.78, is for the supply of AMOX-CLAV 875-125 MG TABLET UD 100S and has an ultimate completion date of January 3, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,040.84 firm-fixed-price contract is for the delivery of AMOX-CLAV 250-125 MG TABLET 30S, a type of antibiotic medication, with a completion date of May 20, 2025. The contract is not set aside and is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order for AMOX-CLAV 500-125 MG TABLET 20S issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,167.95 firm fixed-price contract has a completion date of May 19, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,333.19 firm fixed-price contract is for the supply of Amoxicillin-Clavulanate 1,000-62.5 mg tablets to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,634.87, is for the delivery of AMOX-CLAV ER 1,000-62.5 MG TAB medical supplies. There is no set-aside designation for this award. The delivery order supports DLA Troop Support Medical, which provides pharmaceutical and medical products to military treatment facilities, veterans'...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.35, is for the delivery of Amoxicillin-Clavulanic Acid 250-125 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program and is open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count bottles. The $1,206.01 firm fixed-price contract has an ultimate completion date of August 23, 2024. As a large pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of essential medical commodities to various government agencies and healthcare programs. The...
This federal contract award is for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $1,448.75, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This federal contract award is for a Delivery Order (SPE2DX23FWHVN) issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a division of Cencora, Inc. The $3,708.90 firm fixed-price contract is for the supply of pharmaceutical products, specifically "AMOX-CLAV ER 1000 28S", a prescription medication. This contract is not associated with any set-aside designation and is part of Amerisourcebergen's broader Indefinite...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FETN2
    Delivery Order

This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $1,935.93 and a period of performance through June 16, 2025. The contract is not set aside for a specific business type. Amerisourcebergen Drug Corp is the prime contractor and this award is part of the company's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs and other government agencies through December 2026.

Generated 9/13/25, 9:49 AM